Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Sarcopenia 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Multiple Myeloma 1Metabolic Syndrome 1Lymphoma 1

Interventions

Dexamethasone 116daratumumab 68Lenalidomide 67Bortezomib 55pomalidomide 45carfilzomib 40Cyclophosphamide 33Calcium Dobesilate 32Specimen Handling 30Biopsy 28Magnetic Resonance Spectroscopy 25isatuximab 20belantamab mafodotin 20talquetamab 17iberdomide 17fludarabine 17Melphalan 15dexamethasone acetate 14dexamethasone 21-phosphate 14auricularum 14fludarabine phosphate 11selinexor 10elotuzumab 10tocilizumab 9X-Rays 8Nivolumab 8trametinib 7Sirolimus 7Whole-Body Irradiation 6Mycophenolic Acid 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Multiple Myeloma × maltodextrin × 90 days × Clear all
NCT05135351 2026-04-20

Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy

University of Nebraska

Phase NA Recruiting
30 enrolled
LymphoidPlasma cell

Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡